# SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

> **NCT03623087** · PHASE3 · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 68 (estimated)

## Conditions studied

- Non-Hodgkin's Lymphoma, Relapsed
- Non-Hodgkin T-cell Lymphoma
- Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Gemcitabine
- **DRUG:** Etoposide (VP-16)
- **DEVICE:** Ifosfamide
- **DRUG:** Dexamethasone
- **DRUG:** L-asparaginase

## Key facts

- **NCT ID:** NCT03623087
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2020-03-14
- **Final completion:** 2020-06-30
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2018-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03623087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03623087, "SIMPLE Chemotherapy for NK Lymphoma/Leukaemia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03623087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*